MedTrace Logo

The International ITP Registry

NCT01970189 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2016-10-27

No results posted yet for this study

Summary

Primary immune thrombocytopenia (ITP) is an uncommon disease characterised by a low platelet count, which may cause the patient to have a higher risk or increased duration of bleeding. Individual hospitals only encounter a small number of ITP patients each year which makes it difficult to study this disease. By creating this disease registry, we will be able to build a more complete picture of ITP, including treatment practices, through collecting information about the condition from patients across several hospitals in several countries. Research of this kind will help future patients by providing doctors with information about ITP, and about how patients have been treated.

Conditions

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • South Eastern Sydney Local Health District

    lead OTHER_GOV

Principal Investigators

  • Beng H Chong · SESLHD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2016-12-31
Completion
2020-12-31

Countries

  • Australia
  • Colombia
  • Kuwait
  • Malaysia
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Turkey (Türkiye)
  • Uruguay

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01970189 on ClinicalTrials.gov